Reply to: "Cost-effectiveness of upcoming treatments for hepatitis C: we need to get the models right".
Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA, USA; Betty & Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA. Electronic address: zobair.younossi@inova.org.
Zobair M
ZM
Younossi
Betty & Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA.
Linda
L
Henry
Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA.
Mendel
M
Singer
D000998:Antiviral Agents / Q000008:administration & dosage*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans
D000998:Antiviral Agents